'Antara', included in India's National Family Planning Programme, is:
- A Centchroman 30 mg taken weekly
- B Medroxyprogesterone acetate 104 mg given subcutaneously every 3 months ✓
- C Etonogestrel implant placed subdermally for 3 years
- D Levonorgestrel 1.5 mg single tablet for emergency use
Explanation
Antara is the brand name for the subcutaneous injectable contraceptive DMPA-SC, containing medroxyprogesterone acetate 104 mg, administered every 3 months; it was introduced into the public health programme so ASHAs and MOs could offer injectables. Centchroman weekly tablets are marketed as Chhaya/Saheli, killing option A. Etonogestrel implants are not part of the Indian public programme, and option D describes an emergency contraceptive pill.
Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.